PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT

Title:

PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT

Document Type and Number:

Japanese Patent JP2021183639

Kind Code:

A

Abstract:

To provide injection preparations of fosnetupitant for treatment of diseases mediated by the NK1 receptor, including nausea, emesis and chemotherapy induced nausea and vomiting.SOLUTION: Injectable dosages and formulations of fosnetupitant and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy.SELECTED DRAWING: None

More Like This:

JP2002518448	INDUSTRIAL APPLICABILITY The composition and method for treating high blood cholesterol.
WO/2000/038666	A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
JP2024513079	Antiviral compounds, methods for the manufacture of compounds, antiviral pharmaceutical compositions, uses of those compounds and methods for the oral treatment of coronavirus infections and related diseases

Inventors:

ALESSIO VENTURINI
CANNELLA ROBERTA

Application Number:

JP2021138576A

Publication Date:

December 02, 2021

Filing Date:

August 27, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

HELSINN HEALTHCARE SA

International Classes:

A61K31/661; A61K9/08; A61K31/473; A61K47/02; A61K47/04; A61K47/18; A61K47/26; A61P1/08

Domestic Patent References:

JP2014507446A	2014-03-27
JP2006516583A	2006-07-06

Other References:

PEPTIDES, vol. 69, JPN6021024639, 2015, pages 26 - 32, ISSN: 0004862711

Attorney, Agent or Firm:

Atsushi Aoki
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Kazumi Nakamura

Previous Patent: Conjugate vaccines that target in vivo proteins that cause disease

Next Patent: Prevention, treatment and reversal of diseases using therapeutically effective amounts of activated ...